Zevra Therapeutics, Inc.
ZVRA
$8.39
$0.455.67%
| Weiss Ratings | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.03 | |||
| Price History | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 8.96% | |||
| 30-Day Total Return | 4.61% | |||
| 60-Day Total Return | -1.06% | |||
| 90-Day Total Return | 2.94% | |||
| Year to Date Total Return | -4.22% | |||
| 1-Year Total Return | 36.42% | |||
| 2-Year Total Return | 75.16% | |||
| 3-Year Total Return | 67.80% | |||
| 5-Year Total Return | 161.93% | |||
| 52-Week High % Change | -18.65% | |||
| 52-Week Low % Change | 89.05% | |||
| Price | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $9.76 | |||
| 52-Week Low Price | $4.20 | |||
| 52-Week Low Price (Date) | Jul 05, 2024 | |||
| 52-Week High Price (Date) | Nov 25, 2024 | |||
| Valuation | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 429.68M | |||
| Enterprise Value | 420.48M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.24 | |||
| Earnings Per Share Growth | 75.89% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 17.98 | |||
| Price/Book (Q) | 10.74 | |||
| Enterprise Value/Revenue (TTM) | 17.81 | |||
| Price | $8.39 | |||
| Enterprise Value/EBITDA (TTM) | -5.22 | |||
| Enterprise Value/EBIT | -4.83 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 53.47M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 321 939 3416 | |||
| Address | 1180 Celebration Boulevard Celebration, FL 34747 | |||
| Website | zevra.com | |||
| Country | United States | |||
| Year Founded | 2006 | |||
| Profitability | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -368.46% | |||
| Profit Margin | -446.85% | |||
| Management Effectiveness | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -31.03% | |||
| Return on Equity | -- | |||
| Income Statement | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 23.61M | |||
| Total Revenue (TTM) | 23.61M | |||
| Revenue Per Share | $0.44 | |||
| Gross Profit (TTM) | 16.20M | |||
| EBITDA (TTM) | -80.61M | |||
| EBIT (TTM) | -87.00M | |||
| Net Income (TTM) | -105.51M | |||
| Net Income Avl. to Common (TTM) | -105.51M | |||
| Total Revenue Growth (Q YOY) | -6.79% | |||
| Earnings Growth (Q YOY) | -79.67% | |||
| EPS Diluted (TTM) | -2.24 | |||
| EPS Diluted Growth (Q YOY) | -30.09% | |||
| Balance Sheet | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 69.50M | |||
| Cash Per Share (Q) | $1.30 | |||
| Total Current Assets (Q) | 86.03M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 39.67M | |||
| Current Ratio (Q) | 2.525 | |||
| Book Value Per Share (Q) | $0.74 | |||
| Total Assets (Q) | 178.13M | |||
| Total Current Liabilities (Q) | 34.07M | |||
| Total Debt (Q) | 60.30M | |||
| Total Liabilities (Q) | 138.46M | |||
| Total Common Equity (Q) | 39.67M | |||
| Cash Flow | ZVRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -22.16M | |||
| Cash from Financing (TTM) | 82.11M | |||
| Net Change in Cash (TTM) | -9.26M | |||
| Levered Free Cash Flow (TTM) | -36.75M | |||
| Cash from Operations (TTM) | -69.67M | |||
